Aphios Pharma to Develop FDA-Approved, Cannabis-Based Drugs for Opioid Addiction, Epilepsy and Multiple Sclerosis WOBURN, Mass., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Aphios® Corporation today announced that it is spinning-off Aphios® Pharma to develop FDA-approved, cannabis-based drugs for treating highly unmet...